Brahmer JR, Rodríguez-Abreu D, Robinson AG, et al. Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%. 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 17.06.
Europese consensusaanbevelingen voor oligo-gemetastaseerd slokdarm-/maagcarcinoom
feb 2024 | Maag-darm-leveroncologie